GlassScriptPhysician profile
Annette Laubscher
NPI 1073574281
$1,479.30
in general payments reported to CMS, 2019-2025
24 companies · $19.69 in 2025
The $19.69 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $548 · 2020: $122 · 2021: $286 · 2022: $260 · 2023: $150 · 2024: $94.30 · 2025: $19.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $323.07 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $145.42 | 2021-2023 | |
| Hologic Sales and Service, LLC | $130.28 | 2019-2025 | Thinprep 2000 Processor |
| Pfizer INC. | $129.50 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $108.18 | 2019-2022 | |
| Asensus Surgical, INC. | $74.66 | 2019 | |
| Optumhealth Care Solutions, LLC | $71.72 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Evofem Biosciences, INC. | $54.20 | 2021-2023 | Phexxi |
| Agile Therapeutics, INC. | $48.23 | 2021-2022 | |
| Avion Pharmaceuticals | $45.90 | 2019-2021 | |
| Therapeuticsmd, INC. | $36.82 | 2019 | |
| Merck Sharp & Dohme LLC | $35.93 | 2021 | |
| Lupin INC. | $35.04 | 2019-2021 | |
| Coopersurgical, INC. | $32.09 | 2023 | Summit Doppler |
| Roche Diagnostics Corporation | $30.57 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $27.86 | 2019 | |
| Astellas Pharma US INC | $22.58 | 2024 | Veozah |
| Sumitomo Pharma America, INC. | $21.71 | 2023 | Myfembree |
| Covidien LP | $21.69 | 2020 | |
| Amgen INC. | $21.43 | 2019 | |
| Lsi Solutions INC | $16.91 | 2023 | Fornisee |
| Duchesnay USA Incorporated | $15.59 | 2019 | |
| Coloplast Corp | $15.17 | 2020 | |
| Horizon Therapeutics Plc | $14.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annette Laubscher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.